Trials / Unknown
UnknownNCT03260231
Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma
Effects of Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Belgrade · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Recent literature data suggest beneficial effects of dietary fats in patients with cancers, in particular polyunsaturated fatty acids (PUFAs). Milled mix of flax, sesame and pumpkin seeds provides a high amount of PUFAs and a desirable n-6/n-3 PUFAs ratio.
Detailed description
Cancers are characterized by inflammation and alternations in lipid and fatty acid metabolism. Patients with non-Hodgkin lymphoma have impaired fatty acid profiles, low level of PUFAs, and high n-6/n-3 PUFAs ratio. Moreover, these changes are related to clinical outcome. Flax seeds, sesame and pumpkin seeds are rich sources of PUFAs. Dietary intake of milled mix of these seeds has been shown to decrease inflammation and improve PUFAs status in patients on hemodialysis and to decrease breast cancer risk. The study design is single-blind, controlled, randomized nutritional intervention. The participants are randomly assigned into intervention and control group before starting chemotherapy. All patients receive nutritional counseling to achieve a daily energy and protein intake according to recommended dietary allowances, with (intervention) or without (control) of milled seed mix.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Milled seed mix | Dietary intervention with or without seed mix |
Timeline
- Start date
- 2017-05-12
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2017-08-24
- Last updated
- 2020-03-20
Locations
1 site across 1 country: Serbia
Source: ClinicalTrials.gov record NCT03260231. Inclusion in this directory is not an endorsement.